Treatment of prolonged drug reaction with eosinophilia and systemic symptoms syndrome with dupilumab using a molecularly-guided approach
- PMID: 38774671
- PMCID: PMC11107093
- DOI: 10.1016/j.jdcr.2024.03.020
Treatment of prolonged drug reaction with eosinophilia and systemic symptoms syndrome with dupilumab using a molecularly-guided approach
Keywords: DRESS; RNA in situ hybridization; drug reaction with eosinophilia and systemic symptoms; dupilumab; leflunomide.
Conflict of interest statement
Dr Damsky is a consultant for Pfizer, Incyte, Eli Lilly, and TWi Biotechnology, and has research funding from Pfizer, Advanced Cell Diagnostics/Bio-techne, and AbbVie and receives licensing fees from EMD/Millipore/Sigma, all outside the submitted work. Dr Nelson has received research grants from Boehringer Ingelheim and participated in an advisory board for work related to pustular psoriasis and palmoplantar pustulosis. All other authors have no relevant conflicts to disclose.
Figures
![Fig 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11107093/bin/gr1.gif)
![Fig 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/11107093/bin/gr2.gif)
Similar articles
-
Recurrent Leflunomide-Induced Drug Reaction With Eosinophilia and Systemic Symptom (DRESS) Syndrome Despite Prolonged Steroid Taper: A Case Report.Cureus. 2022 Sep 19;14(9):e29319. doi: 10.7759/cureus.29319. eCollection 2022 Sep. Cureus. 2022. PMID: 36277576 Free PMC article.
-
An Uncommon Presentation of DRESS Syndrome Secondary to Leflunomide Use: A Case Report.J Investig Med High Impact Case Rep. 2021 Jan-Dec;9:2324709621997282. doi: 10.1177/2324709621997282. J Investig Med High Impact Case Rep. 2021. PMID: 33629602 Free PMC article.
-
An unusual case of DRESS syndrome due to leflunomide.BMJ Case Rep. 2011 Sep 4;2011:bcr0620114330. doi: 10.1136/bcr.06.2011.4330. BMJ Case Rep. 2011. PMID: 22679188 Free PMC article.
-
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist.Curr Rheumatol Rep. 2017 Jan;19(1):3. doi: 10.1007/s11926-017-0626-z. Curr Rheumatol Rep. 2017. PMID: 28138822 Review.
-
Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).Int J Mol Sci. 2021 Feb 21;22(4):2147. doi: 10.3390/ijms22042147. Int J Mol Sci. 2021. PMID: 33670052 Free PMC article. Review.
References
-
- Kardaun S.H., Sidoroff A., Valeyrie-Allanore L., et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156(3):609–611. - PubMed
-
- Naranjo C.A., Busto U., Sellers E.M., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245. - PubMed
-
- Uppal M., Rai R., Srinivas C.R. Leflunomide induced drug rash and hepatotoxicity. Indian J Dermatol. 2004;49(3):154–155.
-
- Shastri V., Betkerur J., Kushalappa P.A., Savita T.G., Parthasarathi G. Severe cutaneous adverse drug reaction to leflunomide: a report of five cases. Indian J Dermatol Venereol Leprol. 2006;72(4):286–289. - PubMed
-
- Do-Pham G., Charachon A., Duong T.A., et al. Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases. Br J Dermatol. 2011;165(1):207–209. - PubMed
Publication types
LinkOut - more resources
Full Text Sources